---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-042021"
form_type: "8-K"
ticker: "PAVM"
cik: "0001624326"
company_name: "PAVmed Inc."
filed_at: "2026-09-09T23:15:15+00:00"
generated_at: "2026-09-10T10:05:42.120026+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# PAVmed enters ATM sales agreement to sell up to $9.4M common stock

## Summary
- Agreement with A.G.P./Alliance Global Partners allows at-the-market sales of common stock up to $9,400,000.
- Commission of 3.0% on gross sales; legal fee reimbursements up to $65,000 at execution, $7,500 quarterly, $12,500 per refresh.
- Proceeds to be used for working capital and general corporate purposes.
- Offering under existing shelf registration (File No. 333-283994) effective April 15, 2025; prospectus supplement filed Sept 9, 2026.

## SEC filing metadata
- accession: 0001493152-26-042021
- form_type: 8-K
- ticker: PAVM
- cik: 0001624326
- company_name: PAVmed Inc.
- filed_at: 2026-09-09T23:15:15+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1624326/000149315226042021/0001493152-26-042021-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1624326/000149315226042021/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-042021
- JSON: https://secwatch.observer/filing/0001493152-26-042021.json
- Plain text: https://secwatch.observer/filing/0001493152-26-042021.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.